TrialFrontiers in immunology2023

Anti-interleukin 4 receptor α antibody for the treatment of Chinese bullous pemphigoid patients with diverse comorbidities and a 1-year follow-up: a monocentric real-world study.

Si-Hang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.